A vulnerability in liver tumor cells' nuclear gateways could pave the way for new treatments
A study led by the Cell Cycle and Cancer Group at the Vall d'Hebron Institute of Oncology (VHIO) has identified a vulnerability in liver cancer that could guide the development of new therapies. The work, published in Proceedings ...
5 minutes ago
0
0









